{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:28:17Z","timestamp":1785767297812,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00280-013-2089-x","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T05:49:03Z","timestamp":1359524943000},"page":"965-972","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacodynamic stimulation of thrombogenesis by angiotensin (1\u20137) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy"],"prefix":"10.1007","volume":"71","author":[{"given":"Huyen","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Delmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainoa J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere S.","family":"diZerega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"9","key":"2089_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cc.10.9.15444","volume":"10","author":"X Shen","year":"2011","unstructured":"Shen X, Bernstein K (2011) The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle 10(9):1\u20137","journal-title":"Cell Cycle"},{"key":"2089_CR2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(02)00278-9","volume":"35","author":"C Haznedaroglu","year":"2003","unstructured":"Haznedaroglu C, Ozturk MA (2003) Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 35:867\u2013880","journal-title":"Int J Biochem Cell Biol"},{"key":"2089_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2004.04998.x","volume":"126","author":"WB Strawn","year":"2004","unstructured":"Strawn WB, Richmond RS, Ann TE et al (2004) Renin\u2013angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126:120\u2013126","journal-title":"Br J Haematol"},{"key":"2089_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00280-002-0434-6","volume":"49","author":"KE Rodgers","year":"2002","unstructured":"Rodgers KE, Xiong S, diZerega GS (2002) Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother Pharmacol 49:403\u2013411","journal-title":"Cancer Chemother Pharmacol"},{"key":"2089_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00280-002-0509-4","volume":"51","author":"KE Rodgers","year":"2003","unstructured":"Rodgers KE, Xiong S, diZerega GS (2003) Effect of angiotensin II and angiotensin (1\u20137) on white blood cell recovery after intravenous chemotherapy. Cancer Chemother Pharmacol 51:97\u2013106","journal-title":"Cancer Chemother Pharmacol"},{"key":"2089_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1634\/stemcells.18-4-287","volume":"18","author":"KE Rodgers","year":"2000","unstructured":"Rodgers KE, Xiong S, Steers R et al (2000) Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18:287\u2013294","journal-title":"Stem Cells"},{"key":"2089_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2008.000034","volume":"94","author":"S Heringer-Walther","year":"2009","unstructured":"Heringer-Walther S, Eckert K, Schumacher SM et al (2009) Angiotensin-(1\u20137) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 94:857\u2013860","journal-title":"Haematologica"},{"key":"2089_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","volume":"95","author":"Y Nio","year":"1995","unstructured":"Nio Y, Matsubara H, Murasawa S et al (1995) Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95:46\u201354","journal-title":"J Clin Invest"},{"key":"2089_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(98)00079-5","volume":"57","author":"S Gallinat","year":"1998","unstructured":"Gallinat S, Yu M, Dorst A et al (1998) Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res 57:111\u2013122","journal-title":"Brain Res Mol Brain Res"},{"key":"2089_CR10","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood-2008-03-144766","volume":"112","author":"ET Zambidis","year":"2008","unstructured":"Zambidis ET, Park TS, Yu W et al (2008) Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112:3601\u20133614","journal-title":"Blood"},{"key":"2089_CR11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-005-0078-4","volume":"57","author":"KE Rodgers","year":"2006","unstructured":"Rodgers KE, Oliver J, diZerega GS (2006) Phase I\/II dose escalation study of angiotensin 1\u20137 [A(1\u20137)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother Pharmacol 57:559\u2013568","journal-title":"Cancer Chemother Pharmacol"},{"key":"2089_CR12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2133.2008.08970.x","volume":"160","author":"HW Liu","year":"2009","unstructured":"Liu HW, Cheng B, Li JF et al (2009) Characterization of angiotensin-converting enzyme expression during epidermis morphogenesis in humans: a potential marker for epidermal stem cells. Br J Dermatol 160:250\u2013258","journal-title":"Br J Dermatol"},{"key":"2089_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1387\/ijdb.103097mt","volume":"54","author":"M Tavian","year":"2010","unstructured":"Tavian M, Biasch K, Sinka L et al (2010) Embryonic origin of human hematopoiesis. Int J Dev Biol 54:1061\u20131065","journal-title":"Int J Dev Biol"},{"key":"2089_CR14","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2007-05-091710","volume":"111","author":"VJ Jokubaitis","year":"2008","unstructured":"Jokubaitis VJ, Sinka L, Driessen R et al (2008) Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 111:4055\u20134063","journal-title":"Blood"},{"key":"2089_CR15","doi-asserted-by":"crossref","unstructured":"Sinka L, Biasch K, Khazaal I et al (2012) Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. Blood, prepublished 26 January 2012","DOI":"10.1182\/blood-2010-11-314781"},{"key":"2089_CR16","first-page":"789","volume-title":"Renin and Angiotensin, in Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"LL Brunton","year":"2006","unstructured":"Brunton LL, Lazo JS, Parker KL (2006) Renin and Angiotensin, in Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics 11 edn. NY, Edwin Jackson, New York, pp 789\u2013821","edition":"11"},{"key":"2089_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00280-003-0710-0","volume":"53","author":"DD Ellefson","year":"2004","unstructured":"Ellefson DD, Espinoza T, Roda N et al (2004) Synergistic effects of co-administration of angiotensin 1\u20137 and neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 53:15\u201324","journal-title":"Cancer Chemother Pharmacol"},{"key":"2089_CR18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/09553002.2012.676228","volume":"88","author":"KE Rodgers","year":"2012","unstructured":"Rodgers KE, Espinoza T, Roda N et al (2012) Accelerated hematopoietic recovery with angiotensin-(1\u20137) after total body radiation. Int J Radiat Biol 88:466\u2013476","journal-title":"Int J Radiat Biol"},{"key":"2089_CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/annonc\/mdj979","volume":"17","author":"D Lorusso","year":"2006","unstructured":"Lorusso D, Di Stefano A, Fanfani F et al (2006) Role of gemcitabine in ovarian cancer treatment. Ann Oncol 17:188\u2013194","journal-title":"Ann Oncol"},{"key":"2089_CR20","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.1990.8.12.1935","volume":"8","author":"W Hryniuk","year":"1990","unstructured":"Hryniuk W, Goodyear M (1990) The calculation of received dose intensity. J Clin Oncol 8:1935\u20131937","journal-title":"J Clin Oncol"},{"key":"2089_CR21","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.1991.9.11.2042","volume":"9","author":"D Longo","year":"1991","unstructured":"Longo D, Duffey P, DeVita V et al (1991) The calculation of actual or received dose intensity: a comparison of published methods. J Clin Oncol 9:2042\u20132051","journal-title":"J Clin Oncol"},{"key":"2089_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/cc2857","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J (2004) Statistics review 10: further nonparametric methods. Crit Care 8:196\u2013199","journal-title":"Crit Care"},{"key":"2089_CR23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM199702063360603","volume":"336","author":"M Fanucchi","year":"1997","unstructured":"Fanucchi M, Glaspy J, Crawford J et al (1997) Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med 336:404\u2013409","journal-title":"N Engl J Med"},{"key":"2089_CR24","first-page":"3118","volume":"89","author":"RL Basser","year":"1997","unstructured":"Basser RL, Rasko J, Clarke K et al (1997) Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118\u20133128","journal-title":"Blood"},{"key":"2089_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.exphem.2010.01.004","volume":"38","author":"TA Davis","year":"2010","unstructured":"Davis TA, Landauer MR, Mog SR et al (2010) Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Exp Hematol 38:270\u2013281","journal-title":"Exp Hematol"},{"key":"2089_CR26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2141.2000.02073.x","volume":"109","author":"JE Chisi","year":"2000","unstructured":"Chisi JE, Briscoe CV, Ezan E et al (2000) Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. Br J Haematol 109:563\u2013570","journal-title":"Br J Haematol"},{"key":"2089_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood-2003-11-3828","volume":"104","author":"S Charrier","year":"2004","unstructured":"Charrier S, Michaud A, Badaoui S et al (2004) Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood 104:978\u2013985","journal-title":"Blood"},{"key":"2089_CR28","unstructured":"Australian Government Department of Health and Ageing Schedule of Pharmaceutical Benefits Summary of Changes Document Effective 1 September 2011, pp 23\u201326"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-013-2089-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-013-2089-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-013-2089-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T11:16:07Z","timestamp":1595330167000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-013-2089-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2089"],"URL":"https:\/\/doi.org\/10.1007\/s00280-013-2089-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}